QOOPN

ё
  1. J@Si (2003) Current TherapyA21(3)A272-275Đ
_
  1. Nakamichi, Y., Shukunami, C., Yamada, T., Aihara, K., Kawano, H., Sato, T., Nishizaki, Y., Yamamoto, Y., Shindo, M., Yoshimura, K., Kawaguchi, H., Hiraki, Y., Kato, S (2003) Mol. Cell. Biol., 23: 636-644; Chondromodulin-I (ChM-I) is a bone remodeling factor.
  2. Oshima, Y., Shukunami, C., Honda, J., Nishida, K., Tashiro, F., Miyazaki, J., Hiraki, Y., Tano, Y (2003) Invest. Ophthalmol. Vis. Sci., 44: 1814-1823; Expression and Localization of Tenomodulin, a Transmembrane Type Chondromodulin-I related Angiogenic Inhibitor, in Mouse Eyes.
  3. Kusafuka, K., Luyten, F. P., Bondt, R. D., Hiraki, Y., Shukunami, C., Kayano, T., Takemura, T (2003) Virchows Arch., 442: 482-490; Immunohistochemical evaluation of cartilage-derived morphogenetic protein-1 and -2 in normal human salivary glands and pleomorphic adenomas.
  4. Hayami, T., Funaki, H., Yaoeda, K., Mitui, K., Yamagiwa, H., Tokunaga, K., Hatano, H., Kondo, J., Hiraki, Y., Yamamoto, T., Endo, N (2003) J. Rheumatol., 30: 2207-2217; Expression of the cartilage derived anti-angiogenic factor chondromodulin-I decreases in the early stage of experimental osteoarthritis.
  5. Watanabe, N., Tezuka, Y., Matsuno, K., Miyatani, S., Morimura, N., Yasuda, M., Fujimaki, R., Kuroda, K., Hiraki, Y., Hozumi, N., Tezuka, K (2003) J. Bone Miner. Metab., 21: 344-352; Suppression of differentiation and proliferation of early chondrogenic cells by Notch.